Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2009

View Archived Issues

AVI BioPharma reports efficacy data from phase Ib/II clinical trial of AVI-4658 in DMD

Forest Laboratories to acquire additional rights to NXL-104 under agreement with Novexel

Novel DNA-binding compounds presented by CSIR

GlaxoSmithKline describes nAChR modulators as antipsychotic agents

Mitsubishi Tanabe Pharma discloses novel BK and maxi K+ channel openers

Cathepsin C inhibitors for the treatment of COPD identified by GlaxoSmithKline

Lilly identifies CB1 ligands for the treatment of obesity

New data indicate ridaforolimus-trastuzumab beneficial in refractory metastatic breast cancer

Compugen discovers drug target for treatment of epithelial tumors

Sinovac Biotech files application with SFDA for clinical trial of HFMD vaccine

SemBioSys Genetics presents update of its progress on Apo AI(Milano)

Tego Biosciences sells intellectual property to Luna Innovations

BTC induces apoptosis in PKCalpha overexpressing breast cancer cells

Glycemic control enhanced by adding alogliptin to insulin therapy in type 2 diabetes

Breast cancer growth inhibition seen with JMR-132 and tamoxifen

MVA-BN-HER2 well tolerated, active in phase I breast cancer studies

Tetrathiomolybdate may reduce endothelial progenitor cells in breast cancer patients

EMEA issues negative opinion on Cerepro for malignant brain cancer

Affomix to provide antibodies for Kalgene's diagnostics program

LifeCycle submits phase III protocol for LCP-Tacro trial to the FDA

Vical's phase III trial of Allovectin-7 receives positive safety review

Vivus submits NDA for Qnexa to FDA for treatment of obesity

Arigene terminates tender offer for Trimeris' outstanding shares of common stock

GSK identifies 5-HT2B receptor antagonists for fibrotic conditions and IBS

Gilead describes SCD inhibitors for the treatment of obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...